Prescription drug · ANDA
Benzonatate NDC 51655-776
Benzonatate 200 mg/1 · Capsule · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51655-776-52 | 51655077652 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-776-52)Marketed from Jul 9, 2021 | |
| 51655-776-54 | 51655077654 | 15 CAPSULE in 1 BOTTLE, PLASTIC (51655-776-54)Marketed from Apr 7, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Benzonatate
- Generic name (nonproprietary)
- benzonatate
- Active ingredients
- Benzonatate — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040627
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Tracheobronchial Stretch Receptor Activity (Physiologic effect)
- Identifiers
- Product ID 51655-776_4ba7befd-4844-5d35-e063-6294a90a1a60SPL ID 4ba7befd-4844-5d35-e063-6294a90a1a60SPL set ID da807eb3-349e-61b9-e053-2995a90a0e21RxCUI 283417UNII 5P4DHS6ENR
- Pharmacologic class
- Non-narcotic Antitussive
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451655077652followed by a unit qualifier and the quantityPackage 51655-0776-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE Benzonatate USP is indicated for the symptomatic relief of cough.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040627
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Proficient Rx LP | 71205-971 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Ascend Laboratories, LLC | 67877-573 |
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | Ascend Laboratories, LLC | 67877-575 |
| benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-0688 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Coupler LLC | 67046-1629 |
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | QPharma, Inc. | 42708-082 |
| benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Proficient Rx LP | 63187-928 |
| benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-1329 |